Paradromics at BrainMind 2019
October 14, 2019
The lineup of researchers was impressive, as was the quality of their presentations. Among others, Prof Nick Melosh and Doctor Edward Chang were particularly fascinating: the former described the latest progress in computer brain interfaces, while the latter presented his latest results from his study on speech decoding in the brain, including some audio samples of speech synthesized from neural signals. Other notable presentations included a talk by Patricia Kuhl on the baby brain’s fast development, lab-based detection of autism by Karen Parker, and the benefits of following Circadian cycles by Satchidananda Panda.
The entrepreneurs presentations were another highlight of the conference, showing how neuroscience is rapidly becoming a business opportunity and not only a scientific endeavor. Paradromics presented its differentiated approach to implantable BCI, focusing on concrete healthcare use cases in areas with very high unmet need, such as severely paralyzed patients, sensory impairment and drug resistant mental illness. It announced on stage that it has built the world’s largest scale neural recorder with 10,000 channels, and it is using it to collect preclinical data, with an important data release to happen in the coming weeks. Besides Paradromics three other early stage companies were represented: RocketScience Health, which is developing a novel nasal direct-to-brain drug delivery device, System1 Biosciences that uses cerebral organoids to test drug efficacy, and Inscopix, using optogenetics to study the brain.
BrainMind has really demonstrated that it has become one of the pre-eminent neuroscience and neurotech events in the world, where the key protagonists of the field gather not only to exchange the latest ideas, but also to shape its very future.